278 related articles for article (PubMed ID: 25728286)
21. Changing incidence trends of cutaneous T-cell lymphoma.
Korgavkar K; Xiong M; Weinstock M
JAMA Dermatol; 2013 Nov; 149(11):1295-9. PubMed ID: 24005876
[TBL] [Abstract][Full Text] [Related]
22. Mycosis fungoides in the pediatric population: report from an international Childhood Registry of Cutaneous Lymphoma.
Pope E; Weitzman S; Ngan B; Walsh S; Morel K; Williams J; Stein S; Garzon M; Knobler E; Lieber C; Turchan K; Wargon O; Tsuchiya A
J Cutan Med Surg; 2010; 14(1):1-6. PubMed ID: 20128983
[TBL] [Abstract][Full Text] [Related]
23. Expression of T-follicular helper markers in sequential biopsies of progressive mycosis fungoides and other primary cutaneous T-cell lymphomas.
Bosisio FM; Cerroni L
Am J Dermatopathol; 2015 Feb; 37(2):115-21. PubMed ID: 25406852
[TBL] [Abstract][Full Text] [Related]
24. Myocosis fungoides--an update on a non-mycotic disease.
Makdisi J; Friedman A
J Drugs Dermatol; 2013 Jul; 12(7):825-31. PubMed ID: 23884501
[TBL] [Abstract][Full Text] [Related]
25. Cutaneous T-cell lymphoma: CT in evaluation and staging.
Bass JC; Korobkin MT; Cooper KD; Kane NM; Platt JF
Radiology; 1993 Jan; 186(1):273-8. PubMed ID: 8416579
[TBL] [Abstract][Full Text] [Related]
26. Review of contemporaneous mycosis fungoides and B-cell malignancy at Mayo Clinic.
Herro E; Dicaudo DJ; Davis MD; Weaver AL; Swanson DL
J Am Acad Dermatol; 2009 Aug; 61(2):271-5. PubMed ID: 19481294
[TBL] [Abstract][Full Text] [Related]
27. Paucity of FOXP3+ cells in skin and peripheral blood distinguishes Sézary syndrome from other cutaneous T-cell lymphomas.
Klemke CD; Fritzsching B; Franz B; Kleinmann EV; Oberle N; Poenitz N; Sykora J; Banham AH; Roncador G; Kuhn A; Goerdt S; Krammer PH; Suri-Payer E
Leukemia; 2006 Jun; 20(6):1123-9. PubMed ID: 16557241
[TBL] [Abstract][Full Text] [Related]
28. Epidemiology and clinical manifestations of cutaneous T-cell lymphoma.
Koh HK; Charif M; Weinstock MA
Hematol Oncol Clin North Am; 1995 Oct; 9(5):943-60. PubMed ID: 8522490
[TBL] [Abstract][Full Text] [Related]
29. Cutaneous T cell lymphoma: update on treatment.
Wollina U
Int J Dermatol; 2012 Sep; 51(9):1019-36. PubMed ID: 22909354
[TBL] [Abstract][Full Text] [Related]
30. Evaluation, Diagnosis, and Staging of Cutaneous Lymphoma.
Olsen EA
Dermatol Clin; 2015 Oct; 33(4):643-54. PubMed ID: 26433839
[TBL] [Abstract][Full Text] [Related]
31. Analysis of cutaneous lymphomas in a medical center in Bahia, Brazil.
Bittencourt AL; Oliveira PD; Andrade AC; Santos TC; Oliveira RF; Farré L; Araujo I
Am J Clin Pathol; 2013 Sep; 140(3):348-54. PubMed ID: 23955453
[TBL] [Abstract][Full Text] [Related]
32. The spectrum of cutaneous lymphomas in Japan: a study of 62 cases based on the World Health Organization Classification.
Yasukawa K; Kato N; Kodama K; Hamasaka A; Hata H
J Cutan Pathol; 2006 Jul; 33(7):487-91. PubMed ID: 16872471
[TBL] [Abstract][Full Text] [Related]
33. Primary cutaneous T-cell lymphoma: clinicopathological features and prognostic parameters of 35 cases other than mycosis fungoides and CD30-positive large cell lymphoma.
Beljaards RC; Meijer CJ; Van der Putte SC; Hollema H; Geerts ML; Bezemer PD; Willemze R
J Pathol; 1994 Jan; 172(1):53-60. PubMed ID: 7931828
[TBL] [Abstract][Full Text] [Related]
34. Morbidity and Causes of Death in Patients with Cutaneous T-cell Lymphoma in Finland.
Väkevä L; Lipsanen T; Sintonen H; Ranki A
Acta Derm Venereol; 2017 Jun; 97(6):735-738. PubMed ID: 28175924
[TBL] [Abstract][Full Text] [Related]
35. Nail irregularities associated with Sézary syndrome.
Park K; Reed J; Talpur R; Duvic M
Cutis; 2019 Apr; 103(4):E11-E16. PubMed ID: 31116823
[TBL] [Abstract][Full Text] [Related]
36. Increased malignancy risk in the cutaneous T-cell lymphoma patient population.
Brownell I; Etzel CJ; Yang DJ; Taylor SH; Duvic M
Clin Lymphoma Myeloma; 2008 Apr; 8(2):100-5. PubMed ID: 18501103
[TBL] [Abstract][Full Text] [Related]
37. Incidence and survival patterns of cutaneous T-cell lymphomas in the United States.
Imam MH; Shenoy PJ; Flowers CR; Phillips A; Lechowicz MJ
Leuk Lymphoma; 2013 Apr; 54(4):752-9. PubMed ID: 23004352
[TBL] [Abstract][Full Text] [Related]
38. Relative frequency of the different types of cutaneous T cell and natural killer cell lymphomas in Korea based on the proposed WHO classification and the EORTC classification.
Chang SE; Jee MS; Kim KJ; Choi JH; Sung KJ; Moon KC; Koh JK
J Dermatol; 2003 Jan; 30(1):42-7. PubMed ID: 12598708
[TBL] [Abstract][Full Text] [Related]
39. Biological insights into the pathogenesis of cutaneous T-cell lymphomas (CTCL).
Whittaker S
Semin Oncol; 2006 Feb; 33(1 Suppl 3):S3-6. PubMed ID: 16516668
[TBL] [Abstract][Full Text] [Related]
40. Incidence of primary cutaneous T-cell lymphoma in Norway.
Saunes M; Nilsen TI; Johannesen TB
Br J Dermatol; 2009 Feb; 160(2):376-9. PubMed ID: 18808419
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
